https://health-union.com/wp-content/uploads/2018/10/RA_ia_2018_pressrelease.png
560
1800
Lina Kirby
https://health-union.com/wp-content/uploads/2026/06/healthunion-header-logo.png
Lina Kirby2018-10-03 09:36:452023-05-04 09:54:48Leading Indicators for Why Rheumatoid Arthritis Is MisunderstoodHealth Union’s data-driven industry conversations help pharma make smarter, more effective decisions. Check out our latest thought leadership pieces below.
https://health-union.com/wp-content/uploads/2018/10/RA_ia_2018_pressrelease.png
560
1800
Lina Kirby
https://health-union.com/wp-content/uploads/2026/06/healthunion-header-logo.png
Lina Kirby2018-10-03 09:36:452023-05-04 09:54:48Leading Indicators for Why Rheumatoid Arthritis Is Misunderstood
People Living with Psoriasis and Psoriatic Arthritis Dissatisfied with Current Treatment

WHITEPAPER DOWNLOAD: Patient Experience in Clinical Trials

The secret to sustainable growth: Hiring a mindset, not a skill set
Exploring the Cancer Patient Journey on World Cancer Day and Every Day
Discover the journey of a cancer patient through patient-reported data and personal interviews outlining diagnosis, treatment, and remission.
Type 2 Diabetes Burnout: What Pharma Can Learn
Feelings of diabetes burnout can lead to issues with care management and treatment. Here’s what pharma can learn to help people manage type 2 diabetes.
Seronegative RA and Its Impact on Quality of Life
Survey data shows seronegative RA patients are more likely than those with seropositive rheumatoid arthritis to have been misdiagnosed.
Diagnosis of IBS Is on the Rise, With Little Relief
Since 2017, annual “IBS In America” survey statistics have shown an increased rate of formal IBS diagnosis from a healthcare professional year over year.
Contact
1218 Chestnut St., 3rd Floor
Philadelphia, PA 19107
Phone: 484-985-9715
Fax: 484-450-2513
![]()
Privacy Notice
Terms of Use
Consumer Health Notice
Your Privacy Choices ![]()
Privacy Rights Request Form
Join Our Team
Press Kit




